(Q39550385)

13 September 2017

title

E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT. (English)

1 reference

13 September 2017

Z Wu

1

1 reference

13 September 2017

S Zheng

2

1 reference

13 September 2017

Z Li

3

1 reference

13 September 2017

J Tan

4

1 reference

13 September 2017

Q Yu

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

2 May 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

30

1 reference

13 September 2017

issue

37

1 reference

13 September 2017

page(s)

3979-3984

1 reference

Cancer: Entangled pathways.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Wnt-beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Life and death decisions by the E2F transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Axin localizes to mitotic spindles and centrosomes in mitotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Wnt signalling and its impact on development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Direct coupling of the cell cycle and cell death machinery by E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

The Rb/E2F pathway and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

E2F - at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

The many ways of Wnt in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

E2F1 represses beta-catenin/TCF activity by direct up-regulation of Siah1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.129

21 January 2018

Identifiers

DOI

10.1038/ONC.2011.129

1 reference

13 September 2017

1 reference